Poly(amino acid) Block Copolymer-Based Formulations for Agricultural and Veterinary Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of SN-38 formulations with poly(amino acid) block copolymers to address unmet needs in agricultural and veterinary medicine, enabling novel applications and use cases.
Background and Problem Solved
The original patent disclosed formulations of SN-38 with poly(amino acid) copolymers for chemotherapy applications. However, the potential of this technology extends beyond human healthcare. In agricultural and veterinary medicine, there is a pressing need for effective treatments against plant diseases, parasitic infections, and fungal decay. Current solutions often have limited efficacy, high toxicity, or environmental concerns. The inventive concept addresses these limitations by adapting the core technology to create targeted, controlled-release formulations for these new applications.
Detailed Description of the Inventive Concept
The inventive concept comprises formulations of SN-38 with poly(amino acid) block copolymers tailored for agricultural and veterinary use cases. These formulations can be administered to plants, soil, or animals to treat diseases, improve crop yields, or prevent fungal decay. The poly(amino acid) block copolymer enables controlled release of SN-38, allowing for sustained activity against target pathogens while minimizing environmental impact. The formulations can be delivered through various means, including microfluidic devices, to ensure precise targeting and optimal efficacy.
Novelty and Inventive Step
The inventive concept's novelty lies in its application of the original patent's core technology to entirely new industries and use cases, leveraging the unique properties of poly(amino acid) block copolymers to address specific challenges in agricultural and veterinary medicine. The inventive step involves adapting the formulations and delivery mechanisms to accommodate the distinct requirements of these new applications.
Alternative Embodiments and Variations
Alternative embodiments may include varying the poly(amino acid) block copolymer composition, SN-38 concentration, or delivery mechanism to optimize performance in different agricultural or veterinary contexts. Variations could also involve combining the SN-38 formulations with other active ingredients or adjuvants to enhance efficacy or reduce side effects.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the agricultural and veterinary medicine markets, where there is a growing demand for innovative, effective, and environmentally friendly solutions. Target industries include crop protection, animal health, and wood preservation, with potential applications in organic farming, precision agriculture, and sustainable forestry.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K47/34 |
| A | A61 | A61K9/08 |
| A | A61 | A61K9/19 |
| A | A61 | A61K31/4375 |
| A | A61 | A61K31/513 |
| A | A61 | A61K31/519 |
| A | A61 | A61K45/06 |
| A | A61 | A61K47/26 |
Original Patent Information
| Patent Number | US 11,857,630 |
|---|---|
| Title | Formulations of SN-38 with poly(amino acid) block polymers |
| Assignee(s) | TYNDALL FORMULATION SERVICES, LLC |